Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lah

Showing results (781-790 of 1,064) with videos related to

Pageof 107
Sort By:
The Science of the Total Environment|March 7, 2024
Joint effects of air pollution and neighborhood socioeconomic status on cognitive decline - Mediation by depression, high cholesterol levels, and high blood pressureYiyang Mei, Grace M Christensen, Zhenjiang Li, et al.
The Journal of Biological Chemistry|June 29, 2004
Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissectionLujian Liao, Dongmei Cheng, Jian Wang, et al.
Alzheimer'S Research & Therapy|February 27, 2025
Probing locus coeruleus functional network in healthy aging and its association with Alzheimer's disease biomarkers using pupillometryJunjie Wu, Aaron Toporek, Qixiang Lin, et al.
Harm Reduction Journal|April 12, 2023
Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugsMuhammad Radzi Abu Hassan, Huan-Keat Chan, Mahani Nordin, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 7, 2023
Blood-based biomarkers in Alzheimer's disease: Future directions for implementationIvonne Suridjan, Wiesje M van der Flier, Andreas U Monsch, et al.
Plos One|January 21, 2022
Automated analysis of facial emotions in subjects with cognitive impairmentZifan Jiang, Salman Seyedi, Rafi U Haque, et al.
Neurology|November 1, 2013
Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDPWilliam T Hu, Kelly Watts, Murray Grossman, et al.
EMBO Molecular Medicine|December 2, 2017
A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brainMfon E Umoh, Eric B Dammer, Jingting Dai, et al.
The Journal of Biological Chemistry|January 29, 2003
Endoproteolysis of beta-secretase (beta-site amyloid precursor protein-cleaving enzyme) within its catalytic domain. A potential mechanism for regulationJason T Huse, Damani Byant, Yaxiong Yang, et al.
Biophysical Journal|April 14, 2019
Thermodynamic Stability of the Transcription Regulator PaaR2 from Escherichia coli O157:H7Pieter De Bruyn, San Hadži, Alexandra Vandervelde, et al.
Pageof 107

Showing results (781-790 of 1,064) with videos related to

Sort By:
Pageof 107
The Science of the Total Environment|March 7, 2024
Joint effects of air pollution and neighborhood socioeconomic status on cognitive decline - Mediation by depression, high cholesterol levels, and high blood pressureYiyang Mei, Grace M Christensen, Zhenjiang Li, et al.
The Journal of Biological Chemistry|June 29, 2004
Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissectionLujian Liao, Dongmei Cheng, Jian Wang, et al.
Alzheimer'S Research & Therapy|February 27, 2025
Probing locus coeruleus functional network in healthy aging and its association with Alzheimer's disease biomarkers using pupillometryJunjie Wu, Aaron Toporek, Qixiang Lin, et al.
Harm Reduction Journal|April 12, 2023
Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugsMuhammad Radzi Abu Hassan, Huan-Keat Chan, Mahani Nordin, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 7, 2023
Blood-based biomarkers in Alzheimer's disease: Future directions for implementationIvonne Suridjan, Wiesje M van der Flier, Andreas U Monsch, et al.
Plos One|January 21, 2022
Automated analysis of facial emotions in subjects with cognitive impairmentZifan Jiang, Salman Seyedi, Rafi U Haque, et al.
Neurology|November 1, 2013
Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDPWilliam T Hu, Kelly Watts, Murray Grossman, et al.
EMBO Molecular Medicine|December 2, 2017
A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brainMfon E Umoh, Eric B Dammer, Jingting Dai, et al.
The Journal of Biological Chemistry|January 29, 2003
Endoproteolysis of beta-secretase (beta-site amyloid precursor protein-cleaving enzyme) within its catalytic domain. A potential mechanism for regulationJason T Huse, Damani Byant, Yaxiong Yang, et al.
Biophysical Journal|April 14, 2019
Thermodynamic Stability of the Transcription Regulator PaaR2 from Escherichia coli O157:H7Pieter De Bruyn, San Hadži, Alexandra Vandervelde, et al.
Pageof 107